Pathology of the Thyroid: A Review

  • Virginia A. LiVolsiEmail author
  • Kathleen T. Montone
  • Zubair W. Baloch


This chapter describes the major subtypes and important subtypes of thyroid carcinoma. Both those tumors of follicular and parafollicular origin are included. The cytological and histological features are discussed for each entity. Important pathological prognostic variables are included as these may indicate risk for good or poor prognosis. A short discussion of the major molecular features of the common tumors is also included.


Thyroid cancer Follicular carcinoma Papillary carcinoma Papillary carcinoma variants Medullary carcinoma Unusual thyroid tumors 


  1. 1.
    Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol. 2006;125(Suppl):S135–44.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Deshpande V, Khosroshahi A, Nielsen GP, Hamilos DL, Stone JH. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701–6.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Raess PW, Habashi A, El Rassi E, Milas M, Sauer DA, Troxell ML. Overlapping morphologic and immunohistochemical features of Hashimoto thyroiditis and IgG4-related thyroid disease. Endocr Pathol. 2015;26:170–7.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Li Y, Bai Y, Liu Z, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int. 2009;59:636–41.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRefGoogle Scholar
  6. 6.
    Fujita T. The natural history of multinodular goiter. J Am Coll Surg. 2015;221:893–4.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S. Solitary thyroid nodule: diagnosis and management. Med Clin North Am. 1988;72:1177–211.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    McIver B. Evaluation of the thyroid nodule. Oral Oncol. 2013;49:645–53.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351:1764–71.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Barbaro D, Lapi P, Orsini P, Pasquini C, Piazza F. Ultrasonography in the diagnosis of cancer in multinodular goiter. J Endocrinol Invest. 2002;25:748.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Ogawa Y, Kato Y, Ikeda K, et al. The value of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: an assessment of its diagnostic potential and pitfalls. Surg Today. 2001;31:97–101.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Newkirk KA, Ringel MD, Jelinek J, et al. Ultrasound-guided fine-needle aspiration and thyroid disease. Otolaryngol Head Neck Surg. 2000;123:700–5.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Cappelli C, Castellano M, Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM. 2007;100:29–35.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Baloch ZW, LiVolsi VA. Current role and value of fine-needle aspiration in nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:531–44.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705–15.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab. 2013;98:E1852–60.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Nikiforov YE, Carty SE, Chiosea SI, et al. Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid. 2015;25:1217–23.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Ha EJ, Baek JH, Lee JH, et al. Core needle biopsy could reduce diagnostic surgery in patients with anaplastic thyroid cancer or thyroid lymphoma. Eur Radiol. 2016;26(4):1031–6.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Waisman J, Hernandez O, Ljung BM. Comparison of thyroid fine aspiration and core needle biopsy. Am J Clin Pathol. 2008;129:824. author reply 825.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Khoo TK, Baker CH, Hallanger-Johnson J, et al. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008;14:426–31.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Khayyata S, Barroeta JE, LiVolsi VA, Baloch ZW. Papillary hyperplastic nodule: pitfall in the cytopathologic diagnosis of papillary thyroid carcinoma. Endocr Pract. 2008;14:863–8.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    LiVolsi VA, Merino MJ. Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu. 1994;29:99–120.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Bakhsh A, Kirov G, Gregory JW, Williams ED, Ludgate M. A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocr Relat Cancer. 2006;13:475–83.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Pusztaszeri MP, Krane JF, Cibas ES, Daniels G, Faquin WC. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation. Cancer Cytopathol. 2014;122:666–77.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    LiVolsi VA, Baloch ZW. Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain. Endocr Pathol. 2011;22:184–9.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    LiVolsi VA. Current concepts in follicular tumors of the thyroid. Monogr Pathol. 1993;(35):118–37.Google Scholar
  28. 28.
    McHenry CR, Phitayakorn R. Follicular adenoma and carcinoma of the thyroid gland. Oncologist. 2011;16:585–93.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Mete O, Asa SL. Oncocytes, oxyphils, Hurthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol. 2010;21:16–24.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008;132:1241–50.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Sobrinho-Simoes M, Maximo V, Castro IV, et al. Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol. 2005;13:29–35.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 2012;56:333–9.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38:731–9.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Faquin WC, Wong LQ, Afrogheh AH, et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda system for reporting thyroid cytopathology. Cancer Cytopathol. 2016;124:181–7.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Strickland KC, Howitt BE, Marqusee E, et al. The impact of noninvasive follicular variant of papillary thyroid carcinoma on rates of malignancy for fine-needle aspiration diagnostic categories. Thyroid. 2015;25:987–92.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Elliott DD, Pitman MB, Bloom L, Faquin WC. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108:102–9.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 1987;11:583–91.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 2000;24:575–8.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Salvatore G, Chiappetta G, Nikiforov YE, et al. Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer. 2005;41:816–21.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    DeLellis RA, Lloyd RD, Heitz PU, Eng C. WHO: pathology and genetics. Tumours of endocrine organs. In: Kleihues P, Sobin LE, editors. WHO classification of tumours. Lyon, France: IARC Press; 2004.Google Scholar
  41. 41.
    Agarwal S, Mathur SR, Ray R, Sharma SC, Sinha P. Cytopathological diagnosis of hyalinizing trabecular tumour, a rare thyroid neoplasm. Cytopathology. 2010;21:133–4.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Boerner SL, Asa SL. Hyalinizing trabecular tumor of the thyroid gland: much ado about nothing? Am J Clin Pathol. 2004;122:495–6.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Sosa JA, Udelsman R. Papillary thyroid cancer. Surg Oncol Clin N Am. 2006;15:585–601.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol. 2006;17:1–18.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Barbaro D, Simi U, Meucci G, Lapi P, Orsini P, Pasquini C. Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers – are they different diseases? Clin Endocrinol (Oxf). 2005;63:577–81.CrossRefGoogle Scholar
  46. 46.
    Baloch Z, LiVolsi VA. Pathology of the thyroid gland. Philadelphia, PA: Churchill Livingston; 2002.Google Scholar
  47. 47.
    Baloch ZW, LiVolsi VA. Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow. Expert Rev Mol Diagn. 2005;5:573–84.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Rosai J, DeLellis RA, Carcangiu ML, et al. Tumors of the thyroid and parathyroid glands. Silver Spring, MD: American Registry of Pathology; 2014.Google Scholar
  49. 49.
    Hunt JL, Barnes EL. Non-tumor-associated psammoma bodies in the thyroid. Am J Clin Pathol. 2003;119:90–4.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22:1144–52.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Chernock RD, Lewis JS Jr. Classification of psammoma bodies in the Revised College of American Pathologists thyroid cancer protocol. Arch Pathol Lab Med. 2015;139:967.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol. 2008;215:145–54.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Jovanovic L, Delahunt B, McIver B, et al. Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology. 2010;42:524–33.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Lin X, Finkelstein SD, Zhu B, Silverman JF. Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol. 2008;41:195–203.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Hunt JL, LiVolsi VA, Baloch ZW, et al. Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile. Am J Surg Pathol. 2003;27:159–66.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    So YK, Kim MW, Son YI. Multifocality and bilaterality of papillary thyroid microcarcinoma. Clin Exp Otorhinolaryngol. 2015;8:174–8.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Virk RK, Van Dyke AL, Finkelstein A, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol. 2013;26:62–70.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ. Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:716–9.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Wada N, Masudo K, Nakayama H, et al. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol. 2008;34:202–7.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Landry CS, Grubbs EG, Busaidy NL, et al. Cystic lymph nodes in the lateral neck as indicators of metastatic papillary thyroid cancer. Endocr Pract. 2011;17:240–4.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Kini SR. Thyroid cytopathology an Atlas and text. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.Google Scholar
  62. 62.
    Renshaw AA. “Histiocytoid” cells in fine-needle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern. Cancer. 2002;96:240–3.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011;5:51–6.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 2002;27:143–8.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Ganly I, Ibrahimpasic T, Rivera M, et al. Prognostic implications of papillary thyroid carcinoma with tall-cell features. Thyroid. 2014;24:662–70.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Montone KT, Baloch ZW, Shafique K, et al. Tall cell variant of papillary carcinoma and papillary carcinoma with tall cell features are often underdiagnosed: a retrospective analysis of cases referred for second opinion for clinical management. Lab Invest. 2010;227A:90; abstract 1241.Google Scholar
  67. 67.
    Baloch Z, LiVolsi VA, Tondon R. Aggressive variants of follicular cell derived thyroid carcinoma; the so called ‘real thyroid carcinomas’. J Clin Pathol. 2013;66:733–43.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Ghossein R, Livolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 2008;18:1179–81.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Ghossein RA, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid. 2007;17:655–61.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Ito Y, Hirokawa M, Uruno T, et al. Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology. 2008;40:617–22.CrossRefGoogle Scholar
  71. 71.
    Gopal PP, Montone KT, Baloch Z, Tuluc M, Livolsi V. The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. Thyroid. 2011;21:493–9.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Nikiforov YE. Molecular analysis of thyroid tumors. Mod Pathol. 2011;24(Suppl 2):S34–43.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Dettmer MS, Schmitt A, Steinert H, et al. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer. 2015;22:419–29.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Min HS, Lee C, Jung KC. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population. J Korean Med Sci. 2013;28:534–41.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A. Aggressive variants of papillary thyroid carcinoma. Head Neck. 2011;33:1052–9.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol. 2011;24(Suppl 2):S1–9.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986;85:77–80.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Evans HL. Encapsulated columnar-cell carcinoma of the thyroid. A report of four cases suggesting a favorable outcome. Am J Surg Pathol. 1996;20:1205–11.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Enriquez ML, Baloch Z, Montone KT, Zhang PJ, LiVolsi V. CDX2 Expression in Columnar Cell Variant of Papillary Thyroid Carcinoma. Am J Clin Pathol. 2012;137(5):722–6.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Lastra RR, LiVolsi VA, Baloch ZW. Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective. Cancer Cytopathol. 2014;122:484–503.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44–52.CrossRefGoogle Scholar
  82. 82.
    Lloyd RV, Erickson LA, Asioli S. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol. 2010;34:44–52.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid. 2014;24:958–65.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung CK. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol. 2015;8:7988–97.PubMedPubMedCentralGoogle Scholar
  85. 85.
    LiVolsi VA, Abrosimov AA, Bogdanova T, et al. The Chernobyl thyroid cancer experience: pathology. Clin Oncol. 2011;23:261–7.CrossRefGoogle Scholar
  86. 86.
    Kwak JY, Kim EK, Hong SW, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid gland: specimen radiographic features with histopathological correlation. J Clin Endocrinol Metab. 2009;94:1491–2.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol. 2006;13:176–81.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid. 2009;19:1225–31.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Paner GP, Hunt JL, Ciesla MC, DeJong S, LiVolsi V. Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves’ disease). Endocr Pathol. 2004;15:77–82.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World J Surg. 2009;33:958–62.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Chow SM, Chan JK, Law SC, et al. Diffuse sclerosing variant of papillary thyroid carcinoma—clinical features and outcome. Eur J Surg Oncol. 2003;29:446–9.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Bongiovanni M, Triponez F, McKee TA, Kumar N, Matthes T, Meyer P. Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis; a potential pitfall: a case report and review of the literature. Diagn Cytopathol. 2009;37:671–5.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Lee JY, Shin JH, Han BK, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings. Thyroid. 2007;17:567–73.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Meissner W, Warren S. Tumors of the thyroid gland. Washington, DC: Armed Forces Institute of Pathology; 1969.Google Scholar
  95. 95.
    Xu B, Ghossein R. Encapsulated thyroid carcinoma of follicular cell origin. Endocr Pathol. 2015;26:191–9.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.CrossRefGoogle Scholar
  97. 97.
    Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26:1508–14.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008;130:736–44.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–9.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Baloch ZW, LiVolsi VA. Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med. 2000;124:1192–5.PubMedPubMedCentralGoogle Scholar
  102. 102.
    Ersen A, Durak MG, Canda T, Sevinc AI, Saydam S, Kocdor MA. Warthin-like papillary carcinoma of the thyroid: a case series and review of the literature. Turk Patoloji Derg. 2013;29:150–5.PubMedPubMedCentralGoogle Scholar
  103. 103.
    Ginter PS, Scognamiglio T. Papillary thyroid carcinoma with nodular fasciitis-like stroma: a usual entity with distinctive morphology. Int J Surg Pathol. 2015;23:305–7.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Lee YS, Nam KH, Hong SW, Yun JS, Chung WY, Park CS. Papillary thyroid carcinoma with nodular fasciitis-like stroma. Thyroid. 2008;18:577–8.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Na KY, Kim HS, Sung JY, Park WS, Kim YW. Papillary carcinoma of the thyroid gland with nodular fasciitis-like stroma. Korean J Pathol. 2013;47:167–71.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Scognamiglio T, LiVolsi VA, Baloch ZW. Fine needle aspiration cytology of lipomatous lesions of the thyroid. Diagn Cytopathol. 2006;34:787–9.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Albores-Saavedra J, Housini I, Vuitch F, Snyder WH 3rd. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer. 1997;80:1110–6.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Fukushima M, Ito Y, Hirokawa M, et al. Macrofollicular variant of papillary thyroid carcinoma: its clinicopathological features and long-term prognosis. Endocr J. 2009;56:503–8.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Hunt JL. Unusual thyroid tumors: a review of pathologic and molecular diagnosis. Expert Rev Mol Diagn. 2005;5:725–34.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Mizukami Y, Noguchi M, Michigishi T, et al. Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes. Histopathology. 1992;20:243–50.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Motosugi U, Murata S, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid. 2009;19:535–7.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    LiVolsi VA, Baloch ZW. Predicting prognosis in thyroid carcinoma: can histology do it? Am J Surg Pathol. 2002;26:1064–5.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical- pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol. 2001;25:1478–84.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocr Pathol. 2002;13:3–16.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Nikiforov YE. Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med. 2011;135:569–77.PubMedPubMedCentralGoogle Scholar
  116. 116.
    Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, Simpson K, Angeles A, Henson DE. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol. 2007;31:729–36.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Asanuma K, Sugenoya A, Ohashi T, et al. Pure clear cell papillary thyroid carcinoma with chronic thyroiditis: report of a case. Surg Today. 1998;28:464–6.PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Yazici B, Ertan Y, Oral A, Akgun A. A clear cell variant of papillary thyroid microcarcinoma with lung, bone, and soft tissue metastases. Clin Nucl Med. 2015;40:885–7.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Yang GC, Fried K, Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol. 2013;41:757–61.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Barroeta JE, Baloch ZW, Lal P, Pasha TL, Zhang PJ, LiVolsi VA. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol. 2006;17:225–34.PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, Chapelle Ade L, Kloos RT. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 2005;18:48–57.PubMedCrossRefPubMedCentralGoogle Scholar
  122. 122.
    Rosignolo F, Sponziello M, Durante C, et al. Expression of PAX8 target genes in papillary thyroid carcinoma. PLoS One. 2016;11:e0156658.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Ishigaki K, Namba H, Nakashima M, et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab. 2002;87:3433–40.PubMedPubMedCentralGoogle Scholar
  124. 124.
    Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569–80.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    de Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas. Thyroid. 2015;25:1013–9.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Myung JK, Kwak BK, Lim JA, Lee MC, Kim MJ. TERT promoter mutations and tumor persistence/recurrence in papillary thyroid cancer. Cancer Res Treat. 2016;48:942–7.PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Sun J, Zhang J, Lu J, et al. BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in chinese patients. PLoS One. 2016;11:e0153319.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Yin DT, Yu K, Lu RQ, et al. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2016;85:299–305.CrossRefGoogle Scholar
  129. 129.
    DeLellis RA, Lloyd RD, Heitz PU, Eng C. Pathology & genetics. Tumors of endocrine organs. Lyon: IARC Press; 2004.Google Scholar
  130. 130.
    Baloch ZW, LiVolsi VA. Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology. Endocr Pathol. 2014;25:12–20.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Baloch ZW, LiVolsi VA. Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol. 1999;112:311–6.PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Canberk S, LiVolsi VA, Baloch Z. Oncocytic lesions of the neuroendocrine system. Adv Anat Pathol. 2014;21:69–82.PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hurthle cell carcinoma of the thyroid gland. Thyroid. 2012;22:690–4.PubMedCrossRefPubMedCentralGoogle Scholar
  134. 134.
    Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol. 2002;160:1857–65.PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Maximo V, Sobrinho-Simoes M. Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch. 2000;437:107–15.PubMedCrossRefPubMedCentralGoogle Scholar
  136. 136.
    Gasparre G, Bonora E, Tallini G, Romeo G. Molecular features of thyroid oncocytic tumors. Mol Cell Endocrinol. 2010;321:67–76.PubMedCrossRefPubMedCentralGoogle Scholar
  137. 137.
    Zhang YW, Greenblatt DY, Repplinger D, et al. Older age and larger tumor size predict malignancy in hurthle cell neoplasms of the thyroid. Ann Surg Oncol. 2008;15:2842–6.PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Samulski TD, Bai S, LiVolsi VA, Montone K, Baloch Z. Malignant potential of small oncocytic follicular carcinoma/Hurthle cell carcinoma: an institutional experience. Histopathology. 2013;63:568–73.PubMedPubMedCentralGoogle Scholar
  139. 139.
    Ghossein RA, Hiltzik DH, Carlson DL, et al. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006;106:1669–76.PubMedCrossRefPubMedCentralGoogle Scholar
  140. 140.
    Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol. 2011;35:1866–72.PubMedCrossRefPubMedCentralGoogle Scholar
  141. 141.
    Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A. Poorly differentiated oncocytic thyroid carcinoma—diagnostic implications and outcome. Histopathology. 2012;60:1045–51.PubMedCrossRefPubMedCentralGoogle Scholar
  142. 142.
    Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256–64.PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23:1269–78.PubMedCrossRefPubMedCentralGoogle Scholar
  144. 144.
    Das DK, Janardan C, Pathan SK, George SS, Sheikh ZA. Infarction in a thyroid nodule after fine needle aspiration: report of 2 cases with a discussion of the cause of pitfalls in the histopathologic diagnosis of papillary thyroid carcinoma. Acta Cytol. 2009;53:571–5.PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Kini SR. Post-fine-needle biopsy infarction of thyroid neoplasms: a review of 28 cases. Diagn Cytopathol. 1996;15:211–20.PubMedCrossRefPubMedCentralGoogle Scholar
  146. 146.
    Pinto RG, Couto F, Mandreker S. Infarction after fine needle aspiration. A report of four cases. Acta Cytol. 1996;40:739–41.PubMedCrossRefPubMedCentralGoogle Scholar
  147. 147.
    Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA. Poorly differentiated oncocytic (hurthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015;26:164–9.PubMedCrossRefPubMedCentralGoogle Scholar
  148. 148.
    Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol. 2011;22:190–4.PubMedCrossRefPubMedCentralGoogle Scholar
  149. 149.
    Bongiovanni M, Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Adv Anat Pathol. 2009;16:283–9.PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 2000;88:1902–8.CrossRefGoogle Scholar
  151. 151.
    Baroli A, Pedrazzini L, Lomuscio G, Marzoli L. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution. Minerva Endocrinol. 2010;35:9–16.PubMedPubMedCentralGoogle Scholar
  152. 152.
    Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003;88:5399–404.PubMedCrossRefPubMedCentralGoogle Scholar
  153. 153.
    Rodrigues RF, Roque L, Rosa-Santos J, Cid O, Soares J. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer. 2004;90:492–6.PubMedPubMedCentralCrossRefGoogle Scholar
  154. 154.
    Zou M, Shi Y, Farid NR. p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab. 1993;77:1054–8.PubMedPubMedCentralGoogle Scholar
  155. 155.
    Jin L, Chen E, Dong S, et al. BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients. Oncotarget. 2016;7:18346–55.PubMedPubMedCentralGoogle Scholar
  156. 156.
    Xing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32:2718–26.PubMedPubMedCentralCrossRefGoogle Scholar
  157. 157.
    Ha EJ, Baek JH, Lee JH, et al. Core needle biopsy could reduce diagnostic surgery in patients with anaplastic thyroid cancer or thyroid lymphoma. Eur Radiol. 2016;26:1031–6.PubMedCrossRefPubMedCentralGoogle Scholar
  158. 158.
    Suh HJ, Moon HJ, Kwak JY, Choi JS, Kim EK. Anaplastic thyroid cancer: ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy. Yonsei Med J. 2013;54:1400–6.PubMedPubMedCentralCrossRefGoogle Scholar
  159. 159.
    Raue F, Frank-Raue K. Long-term follow-up in medullary thyroid carcinoma. Recent Results Cancer Res. 2015;204:207–25.PubMedCrossRefPubMedCentralGoogle Scholar
  160. 160.
    Raue F, Frank-Raue K. Epidemiology and clinical presentation of medullary thyroid carcinoma. Recent Results Cancer Res. 2015;204:61–90.PubMedCrossRefPubMedCentralGoogle Scholar
  161. 161.
    Marques P, Vieira Mda S, Bugalho MJ. Ectopic cushing in a patient with medullary thyroid carcinoma: hypercortisolism control and tumor reduction with Sunitinib. Endocrine. 2015;49:290–2.PubMedCrossRefPubMedCentralGoogle Scholar
  162. 162.
    Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol. 2001;12:365–77.PubMedCrossRefPubMedCentralGoogle Scholar
  163. 163.
    Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13:69–75.PubMedCrossRefPubMedCentralGoogle Scholar
  164. 164.
    Samulski TD, Livolsi VA, Montone K, Baloch Z. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience. Pathol Res Pract. 2014;210:182–5.PubMedCrossRefPubMedCentralGoogle Scholar
  165. 165.
    Baloch ZW, LiVolsi VA. C-cells and their associated lesions and conditions: a pathologists perspective. Turk Patoloji Derg. 2015;31(Suppl 1):60–79.PubMedPubMedCentralGoogle Scholar
  166. 166.
    Guyetant S, Saint-Andre JP. C cell hyperplasia and medullary microcarcinomas of the thyroid. Ann Pathol. 2000;20(Suppl):S39–44.PubMedPubMedCentralGoogle Scholar
  167. 167.
    Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med. 2008;132:1767–73.PubMedPubMedCentralGoogle Scholar
  168. 168.
    Fukushima M, Ito Y, Hirokawa M, et al. Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule. World J Surg. 2009;33:963–8.PubMedCrossRefPubMedCentralGoogle Scholar
  169. 169.
    Hillenbrand A, Varhaug JE, Brauckhoff M, et al. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Langenbecks Arch Surg. 2010;395:851–8.PubMedCrossRefPubMedCentralGoogle Scholar
  170. 170.
    Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C. Long-term prognosis of medullary thyroid carcinoma. Clin Endocrinol (Oxf). 2008;69:497–505.CrossRefGoogle Scholar
  171. 171.
    Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107:2134–42.PubMedCrossRefPubMedCentralGoogle Scholar
  172. 172.
    Voutilainen PE, Multanen M, Haapiainen RK, Haglund CH, Sane T, Sivula AH. Long term prognosis of medullary thyroid carcinoma in 39 patients. Ann Chir Gynaecol. 2000;89:292–7.PubMedPubMedCentralGoogle Scholar
  173. 173.
    Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610.PubMedPubMedCentralCrossRefGoogle Scholar
  174. 174.
    Papaparaskeva K, Nagel H, Droese M. Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol. 2000;22:351–8.PubMedCrossRefPubMedCentralGoogle Scholar
  175. 175.
    Tranchida P, Estigarribia J, Sethi S, Giorgadze T. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature. Diagn Cytopathol. 2011;39:641–6.PubMedCrossRefPubMedCentralGoogle Scholar
  176. 176.
    Rabitti C, Fadda G, Minimo C, Coronetta F, Russo RM, Capelli A. Preoperative cytologic diagnosis of medullary carcinoma of the thyroid. Pathologica. 1989;81:171–7.PubMedPubMedCentralGoogle Scholar
  177. 177.
    de Crea C, Raffaelli M, Maccora D, et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngol Ital. 2014;34:399–405.PubMedPubMedCentralGoogle Scholar
  178. 178.
    Trimboli P, Guidobaldi L, Bongiovanni M, Crescenzi A, Alevizaki M, Giovanella L. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: a systematic review. Diagn Cytopathol. 2016;44:45–51.PubMedCrossRefPubMedCentralGoogle Scholar
  179. 179.
    Oh SY, Kim WS, Kim JS, et al. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease – consortium for improving survival of lymphoma study. Acta Haematol. 2011;127:100–4.PubMedCrossRefPubMedCentralGoogle Scholar
  180. 180.
    Sarinah B, Hisham AN. Primary lymphoma of the thyroid: diagnostic and therapeutic considerations. Asian J Surg. 2010;33:20–4.PubMedCrossRefPubMedCentralGoogle Scholar
  181. 181.
    Straus DJ. Primary thyroid lymphoma, a rare disease with a good treatment outcome. J Surg Oncol. 2010;101:543–4.PubMedCrossRefPubMedCentralGoogle Scholar
  182. 182.
    Wirtzfeld DA, Winston JS, Hicks WL Jr, Loree TR. Clinical presentation and treatment of non-Hodgkin’s lymphoma of the thyroid gland. Ann Surg Oncol. 2001;8:338–41.PubMedPubMedCentralGoogle Scholar
  183. 183.
    Lee CH, Jung YY, Chung YR, Ryu HS. Liquid-based cytologic findings of solitary extramedullary plasmacytoma in thyroid: a case report identified with fine-needle aspiration cytology. Diagn Cytopathol. 2014;42:964–9.PubMedCrossRefPubMedCentralGoogle Scholar
  184. 184.
    Hassan MJ, Khans S, Pujani M, Jetley S, Raina PK, Ahmad R. Extramedullary plasmacytoma of the thyroid: report of a rare case. Blood Res. 2014;49:280–3.PubMedPubMedCentralCrossRefGoogle Scholar
  185. 185.
    Gomez-De La Fuente E, Ortiz PL, Vanaclocha F, Rodriguez-Peralto JL, Iglesias L. Aggressive granulomatous mycosis fungoides with clinical pulmonary and thyroid involvement. Br J Dermatol. 2000;142:1026–9.PubMedCrossRefPubMedCentralGoogle Scholar
  186. 186.
    Powell JG, Goellner JR, Nowak LE, McIver B. Rosai-Dorfman disease of the thyroid masquerading as anaplastic carcinoma. Thyroid. 2003;13:217–21.PubMedCrossRefPubMedCentralGoogle Scholar
  187. 187.
    Chong VF. Langerhans cell histiocytosis with thyroid involvement. Eur J Radiol. 1996;22:155–7.PubMedCrossRefPubMedCentralGoogle Scholar
  188. 188.
    Lindley R, Hoile R, Schofield J, Ashton-Key M. Langerhans cell histiocytosis associated with papillary carcinoma of the thyroid. Histopathology. 1998;32:180.PubMedCrossRefPubMedCentralGoogle Scholar
  189. 189.
    Babu N, Dey P. Fine needle aspiration cytology of non-Hodgkin’s lymphoma of thyroid. Cytopathology. 2002;13:188.PubMedCrossRefPubMedCentralGoogle Scholar
  190. 190.
    Al-Ghamdi S, Fageeh N, Dewan M. Malignant schwannoma of the thyroid gland. Otolaryngol Head Neck Surg. 2000;122:143–4.PubMedCrossRefPubMedCentralGoogle Scholar
  191. 191.
    An J, Oh YL, Shin JH, Jeong HS. Primary schwannoma of the thyroid gland: a case report. Acta Cytol. 2010;54:857–62.PubMedPubMedCentralGoogle Scholar
  192. 192.
    Baloch ZW, Martin S, Livolsi VA. Granular cell tumor of the thyroid: a case report. Int J Surg Pathol. 2005;13:291–4.PubMedCrossRefPubMedCentralGoogle Scholar
  193. 193.
    Bowry M, Almeida B, Jeannon JP. Granular cell tumour of the thyroid gland: a case report and review of the literature. Endocr Pathol. 2011;22:1–5.PubMedCrossRefPubMedCentralGoogle Scholar
  194. 194.
    Papi G, Corrado S, Ruggiero C, Livolsi VA. Solitary fibrous tumor of the thyroid gland associated with papillary thyroid carcinoma. Thyroid. 2006;16:319–20.PubMedCrossRefPubMedCentralGoogle Scholar
  195. 195.
    Mansouri H, Gaye M, Errihani H, Kettani F, Gueddari BE. Leiomyosarcoma of the thyroid gland. Acta Otolaryngol. 2008;128:335–6.PubMedCrossRefPubMedCentralGoogle Scholar
  196. 196.
    Giorgadze T, Ward RM, Baloch ZW, LiVolsi VA. Phyllodes tumor metastatic to thyroid Hurthle cell adenoma. Arch Pathol Lab Med. 2002;126:1233–6.PubMedPubMedCentralGoogle Scholar
  197. 197.
    Cameselle-Teijeiro J, Menasce LP, Yap BK, et al. Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol. 2009;131:134–42.PubMedCrossRefPubMedCentralGoogle Scholar
  198. 198.
    Xu B, Yoshimoto K, Miyauchi A, et al. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol. 2003;199:58–67.PubMedCrossRefPubMedCentralGoogle Scholar
  199. 199.
    Hirokawa M, Kuma S, Miyauchi A, et al. Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. Apmis. 2004;112:275–82.PubMedCrossRefPubMedCentralGoogle Scholar
  200. 200.
    Subramaniam MM, Putti TC, Anuar D, et al. Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis. Am J Clin Pathol. 2007;128:994–1001.PubMedCrossRefPubMedCentralGoogle Scholar
  201. 201.
    Cameselle-Teijeiro J, Fachal C, Cabezas-Agricola JM, et al. Thyroid pathology findings in Cowden syndrome: a clue for the diagnosis of the PTEN hamartoma tumor syndrome. Am J Clin Pathol. 2015;144:322–8.PubMedCrossRefPubMedCentralGoogle Scholar
  202. 202.
    Laury AR, Bongiovanni M, Tille JC, Kozakewich H, Nose V. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid. 2011;21:135–44.PubMedCrossRefPubMedCentralGoogle Scholar
  203. 203.
    Barletta JA, Bellizzi AM, Hornick JL. Immuno histochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol. 2011;35:1505–11.PubMedCrossRefPubMedCentralGoogle Scholar
  204. 204.
    Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol. 2000;13:802–7.PubMedCrossRefPubMedCentralGoogle Scholar
  205. 205.
    Sim SJ, Ro JY, Ordonez NG, Cleary KR, Ayala AG. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: report of two patients, one with distant metastasis, and review of the literature. Hum Pathol. 1997;28:1091–6.PubMedCrossRefPubMedCentralGoogle Scholar
  206. 206.
    Wenig BM, Adair CF, Heffess CS. Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial-derived tumor. Hum Pathol. 1995;26:1099–108.PubMedCrossRefPubMedCentralGoogle Scholar
  207. 207.
    Farhat NA, Faquin WC, Sadow PM. Primary mucoepidermoid carcinoma of the thyroid gland: a report of three cases and review of the literature. Endocr Pathol. 2013;24:229–33.PubMedCrossRefPubMedCentralGoogle Scholar
  208. 208.
    Prichard RS, Lee JC, Gill AJ, et al. Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid. 2012;22:205–9.PubMedCrossRefPubMedCentralGoogle Scholar
  209. 209.
    Bondeson L, Bondeson AG. Cytologic features in fine-needle aspirates from a sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. Diagn Cytopathol. 1996;15:301–5.PubMedCrossRefPubMedCentralGoogle Scholar
  210. 210.
    Dettloff J, Seethala RR, Stevens TM, et al. Mammary analog secretory carcinoma (MASC) involving the thyroid gland: a report of the first 3 cases. Head Neck Pathol. 2017;11(2):124–30.PubMedCrossRefPubMedCentralGoogle Scholar
  211. 211.
    Dogan S, Wang L, Ptashkin RN, et al. Mammary analog secretory carcinoma of the thyroid gland: a primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Mod Pathol. 2016;29(9):985–95.PubMedPubMedCentralCrossRefGoogle Scholar
  212. 212.
    Reynolds S, Shaheen M, Olson G, Barry M, Wu J, Bocklage T. A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off. Head Neck Pathol. 2016;10(3):405–13.PubMedPubMedCentralCrossRefGoogle Scholar
  213. 213.
    Abrosimov AY, LiVolsi VA. Spindle epithelial tumor with thymus-like differentiation (SETTLE) of the thyroid with neck lymph node metastasis: a case report. Endocr Pathol. 2005;16:139–43.PubMedCrossRefPubMedCentralGoogle Scholar
  214. 214.
    Cheuk W, Jacobson AA, Chan JK. Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential. Mod Pathol. 2000;13:1150–5.PubMedCrossRefPubMedCentralGoogle Scholar
  215. 215.
    Folpe AL, Lloyd RV, Bacchi CE, Rosai J. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol. 2009;33:1179–86.PubMedCrossRefPubMedCentralGoogle Scholar
  216. 216.
    Haberal AN, Aydin H, Turan E, Demirhan B. Unusual spindle cell tumor of thyroid (SETTLE). Thyroid. 2008;18:85–7.PubMedCrossRefPubMedCentralGoogle Scholar
  217. 217.
    Chan JK, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol. 1991;22:349–67.PubMedCrossRefPubMedCentralGoogle Scholar
  218. 218.
    Chan LP, Chiang FY, Lee KW, Kuo WR. Carcinoma showing thymus-like differentiation (CASTLE) of thyroid: a case report and literature review. Kaohsiung J Med Sci. 2008;24:591–7.PubMedCrossRefPubMedCentralGoogle Scholar
  219. 219.
    Musella M, De Franciscis S, Amorosi A, et al. CASTLE tumour of the thyroid. Value of multiplanar imaging acquisition. Ann Ital Chir. 2006;77:509–12.PubMedPubMedCentralGoogle Scholar
  220. 220.
    Reimann JD, Dorfman DM, Nose V. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol. 2006;30:994–1001.PubMedCrossRefPubMedCentralGoogle Scholar
  221. 221.
    Roka S, Kornek G, Schuller J, Ortmann E, Feichtinger J, Armbruster C. Carcinoma showing thymic-like elements—a rare malignancy of the thyroid gland. Br J Surg. 2004;91:142–5.PubMedCrossRefPubMedCentralGoogle Scholar
  222. 222.
    Youens KE, Bean SM, Dodd LG, Jones CK. Thyroid carcinoma showing thymus-like differentiation (CASTLE): case report with cytomorphology and review of the literature. Diagn Cytopathol. 2011;39:204–9.PubMedPubMedCentralGoogle Scholar
  223. 223.
    LaGuette J, Matias-Guiu X, Rosai J. Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol. 1997;21:748–53.PubMedCrossRefPubMedCentralGoogle Scholar
  224. 224.
    Basu S, Viswanathan S. Primary paraganglioma of thyroid presenting as solitary thyroid mass. J Cancer Res Ther. 2011;7:385–7.PubMedCrossRefPubMedCentralGoogle Scholar
  225. 225.
    Castelblanco E, Gallel P, Ros S, et al. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results. Hum Pathol. 2012;43:1103–12.PubMedCrossRefPubMedCentralGoogle Scholar
  226. 226.
    Ferri E, Manconi R, Armato E, Ianniello F. Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical study with review of the literature. Acta Otorhinolaryngol Ital. 2009;29:97–102.PubMedPubMedCentralGoogle Scholar
  227. 227.
    Shi C, Guan H, Qi W, et al. Intrathyroidal parathyroid adenoma: diagnostic pitfalls on fine-needle aspiration: two case reports and literature review. Diagn Cytopathol. 2016;44(11):921–5.PubMedCrossRefPubMedCentralGoogle Scholar
  228. 228.
    Yalcin Y, Mete T, Aktimur R, et al. A case of primary hyperparathyroidism due to intrathyroidal parathyroid cyst. Case Rep Endocrinol. 2014;2014:213283.PubMedPubMedCentralGoogle Scholar
  229. 229.
    Kim BS, Ryu HS, Kang KH, Park SJ. Intrathyroidal parathyroid hyperplasia in tertiary hyperparathyroidism. J Surg Case Rep. 2013;2013(5).PubMedPubMedCentralCrossRefGoogle Scholar
  230. 230.
    Cating-Cabral MT, Cabungcal AC, Villafuerte CV, 3rd, Anel-Quimpo J. Primary hyperparathyroidism due to an intrathyroidal parathyroid adenoma associated with chronic lymphocytic thyroiditis. BMJ Case Rep. 2012;2012.Google Scholar
  231. 231.
    Temmim L, Sinowatz F, Hussein WI, Al-Sanea O, El-Khodary H. Intrathyroidal parathyroid carcinoma: a case report with clinical and histological findings. Diagn Pathol. 2008;3:46.PubMedPubMedCentralCrossRefGoogle Scholar
  232. 232.
    Yusim A, Aspelund G, Ahrens W, et al. Intrathyroidal parathyroid adenoma. Thyroid. 2006;16:619–20.PubMedCrossRefPubMedCentralGoogle Scholar
  233. 233.
    Dutta D, Selvan C, Kumar M, et al. Needle aspirate PTH in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid cyst. Endocrinol Diabetes Metab Case Rep. 2013;2013:130019.PubMedPubMedCentralGoogle Scholar
  234. 234.
    Rossi ED, Mule A, Zannoni GF, Fadda G. Asymptomatic intrathyroidal parathyroid adenoma. Report of a case with a cytologic differential diagnosis including thyroid neoplasms. Acta Cytol. 2004;48:437–40.PubMedCrossRefPubMedCentralGoogle Scholar
  235. 235.
    Lee KM, Kim EJ, Choi WS, Park WS, Kim SW. Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient. J Clin Ultrasound. 2014;42:212–4.PubMedCrossRefPubMedCentralGoogle Scholar
  236. 236.
    Vila Duckworth L, Winter WE, Vaysberg M, Moran CA, Al-Quran SZ. Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature. Case Rep Pathol. 2013;2013:198643.PubMedPubMedCentralGoogle Scholar
  237. 237.
    Russell JO, Yan K, Burkey B, Scharpf J. Nonthyroid metastasis to the thyroid gland: case series and review with observations by primary pathology. Otolaryngol Head Neck Surg. 2016;155(6):961–8.PubMedCrossRefPubMedCentralGoogle Scholar
  238. 238.
    Kefeli M, Mete O. An unusual solitary thyroid nodule with bloody follicles: metastatic renal cell carcinoma within an infiltrative follicular variant papillary carcinoma. Endocr Pathol. 2016;27:171–4.PubMedCrossRefPubMedCentralGoogle Scholar
  239. 239.
    Koo HL, Jang J, Hong SJ, Shong Y, Gong G. Renal cell carcinoma metastatic to follicular adenoma of the thyroid gland. A case report. Acta Cytol. 2004;48:64–8.PubMedCrossRefPubMedCentralGoogle Scholar
  240. 240.
    Bohn OL, De las Casas LE, Leon ME. Tumor-to-tumor metastasis: renal cell carcinoma metastatic to papillary carcinoma of thyroid-report of a case and review of the literature. Head Neck Pathol. 2009;3:327–30.PubMedPubMedCentralCrossRefGoogle Scholar
  241. 241.
    Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H. Metastasis to the thyroid gland: report of a large series from the Mayo Clinic. Am J Clin Oncol. 2015;38:338–42.PubMedCrossRefPubMedCentralGoogle Scholar
  242. 242.
    Ciobanu D, Vulpoi C, Galusca B, Florea N, Giusca SE, Caruntu ID. The value of the immunohistochemical exam in the diagnosis of the secondary malignant tumors to the thyroid gland. Rom J Morphol Embryol. 2007;48:113–9.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Virginia A. LiVolsi
    • 1
    Email author
  • Kathleen T. Montone
    • 1
  • Zubair W. Baloch
    • 1
  1. 1.Department of Pathology and Laboratory MedicinePerelman School of Medicine of the University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations